Large multimodal foundation model for radiation oncology

Large multimodal foundation model for radiation oncology. Image courtesy of Chenbin Liu


December 20, 2023 — An estimated 600,000 people in the United States succumb to cancer every year. Beyond surgery, chemotherapy, and immunotherapy, radiotherapy has shown to be a  standard and effective treatment option for nearly 50-70 percent of cancer patients.

Radiotherapy treatment involves six basic stages: initial consultation, simulation, treatment planning, treatment delivery, treatment verification and patient follow-up. With the emergence of Artificial intelligence (AI), radiotherapy is undergoing substantial transformation. AI achieves human-level accuracy in the auto-segmentation, tumor staging, image registration, automatic treatment planning, quality assurance and outcomes prediction, which greatly improves the accuracy, precision, and efficiency of radiation therapy.

According to a recent review published in the KeAi journal Meta-Radiology, pioneering AGI models, such as GPT-4 and PaLM 2, along with large vision models (LVMs) like the Segment Anything Model (SAM), are capable of processing extensive texts and imaging data, respectively. AGI, distinguished by its advanced capabilities in few-shot and zero-shot learning, offers a pathway towards developing highly robust and generalizable AI models. These models are imperative for seamless and effective integration into the various facets of radiation oncology.

They found that the fusion of vision data with LLMs also creates powerful multimodal models that elucidate nuanced clinical patterns. Together, AGI has the potential to catalyze a shift towards data-driven, personalized radiation therapy. The authors stressed that these models should complement human expertise and care.

The findings provide an overview of how AGI can transform radiation oncology to elevate the standard of patient care, with the key insight being AGI’s ability to exploit multimodal clinical data at scale. In addition, the researchers explore the future directions of AGI in radiation oncology and discuss potential developments and bottlenecks in this field. These advancements in clinical applications will further enhance the effectiveness of radiation therapy, bringing more positive outcomes for cancer patients.

For more information: https://www.mayoclinic.org/


Related Content

News | Magnetic Resonance Imaging (MRI)

March 25, 2026 A Penn Medicine–led team has developed a first‑of‑its‑kind artificial intelligence system that interprets ...

Time March 26, 2026
arrow
News | Cybersecurity

March 23, 2026 —Sacumen has launched ConnectX, a unified AI platform that gives cybersecurity product companies full ...

Time March 25, 2026
arrow
News | FDA

March 20, 2026 — Siemens Healthineers recently announced its Varian TrueBeam radiotherapy systems, which include ...

Time March 24, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 18, 2026 — GE HealthCare and Springbok Analytics have entered a development agreement that will aim to leverage ...

Time March 18, 2026
arrow
News | Radiology Education

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...

Time March 17, 2026
arrow
News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
News | HIMSS

March 9, 2026 — Fujifilm Healthcare Americas Corp. is showcasing how its latest AI-powered enterprise imaging solutions ...

Time March 10, 2026
arrow
News | HIMSS

March 5, 2026 — At the Health Information and Management Systems Society (HIMSS) Conference & Exhibition 2026 in Las ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Ultrasound Women's Health

March 2, 2026 — Ultrasound AI, a provider of artificial intelligence applications for medical imaging, has received FDA ...

Time March 03, 2026
arrow
Subscribe Now